Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2021

10.09.2020 | Review

Impalpable breast lesion localisation, a logistical challenge: results of the UK iBRA-NET national practice questionnaire

verfasst von: Santosh K. Somasundaram, Shelley Potter, Suzanne Elgammal, Anthony J. Maxwell, Amtul S. Sami, Sue K. Down, Rajiv V. Dave, James Harvey

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Breast conserving surgery of impalpable breast lesions requires safe and effective localisation techniques. Wire localisation has traditionally been used, but has limitations. Newer techniques are now being introduced to mitigate this. The iBRA-NET group aims to robustly evaluate these new techniques in well-designed prospective studies. We report the first phase of this evaluation, a survey to establish current practice and service provision of breast localisation techniques in the UK.

Methods

A national practice questionnaire was designed using ‘SurveyMonkey®’ and was circulated to UK breast surgeons via the Association of Breast Surgery and the Mammary Fold. The questionnaire was live from 6th October 2018 to 6th April 2019. Only one response per unit was requested to reflect the unit’s practice.

Results

Complete responses were received from 98 breast units across the UK. Wires were the mostly commonly used localisation technique (n = 82) with fewer units using Magseed® (n = 9), Radioguided Occult Lesion Localisation (n = 5) and Radioiodine Seed Localisation (n = 2). There was significant variation in practice and logistics involved. Frequent delays and theatre overruns were reported in 39 and 16 units, respectively. The median satisfaction score of the current technique was 7 out of 10. The main perceived limitation of existing localisation methods was logistics affecting theatre scheduling and the main barrier to introducing a new technique was cost.

Conclusion

Wires are currently the most commonly used localisation technique but are associated with significant logistical issues. Newer techniques may offer a better solution but will need robust evaluation before they are adopted to ensure safety and efficacy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
4.
Zurück zum Zitat Franceschini G, Di Leone A, Natale M, Sanchez MA, Masett R (2018) Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer. Ann Ital Chir 89:290PubMed Franceschini G, Di Leone A, Natale M, Sanchez MA, Masett R (2018) Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer. Ann Ital Chir 89:290PubMed
5.
Zurück zum Zitat Dodd GD, Fry K, Delany W (1965) Preoperative localization of occult carcinoma of the breast. In: Nealon TF (ed) Management of the patient with cancer. Saunders, Philadelphia, pp 88–113 Dodd GD, Fry K, Delany W (1965) Preoperative localization of occult carcinoma of the breast. In: Nealon TF (ed) Management of the patient with cancer. Saunders, Philadelphia, pp 88–113
6.
Zurück zum Zitat Rahusen FD, Bremers AJA, Fabry HFJ, van Amerongen AHMT, Boom RPA, Meijer S (2002) Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol 9:994–998CrossRef Rahusen FD, Bremers AJA, Fabry HFJ, van Amerongen AHMT, Boom RPA, Meijer S (2002) Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol 9:994–998CrossRef
7.
Metadaten
Titel
Impalpable breast lesion localisation, a logistical challenge: results of the UK iBRA-NET national practice questionnaire
verfasst von
Santosh K. Somasundaram
Shelley Potter
Suzanne Elgammal
Anthony J. Maxwell
Amtul S. Sami
Sue K. Down
Rajiv V. Dave
James Harvey
Publikationsdatum
10.09.2020
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2021
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-020-05918-6

Weitere Artikel der Ausgabe 1/2021

Breast Cancer Research and Treatment 1/2021 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.